Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a…
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it…
Just Do It… the Best You Can with Compassion for Others AND Yourself
With six weeks left in the year, this newsletter should be all about getting in gear for the 2021 planning cycle. Or, maybe, it should be about Q1,…
Reverse Mentoring with Up-and-Coming Talent
In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why…
How to Write the Biopharma S-1 Business Section
Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1 filings — coordinating with…
There Is No Such Thing as a Free Launch!
We are fortunate to work with clients of all sizes, whose products are at various stages of their life cycle. But the angst around how to achieve a…
Making Virtual Workshops Work
Workshops, whether in the form of a half-day strategy session, a company-wide offsite or some other configuration, have one thing in common: They…
What’s Different Now
In just one month, life for all of us has changed dramatically. This week, we learned that the new normal would extend at least through April,…
How to Work Remotely
I write this on the day the World Health Organization (WHO) has declared Covid-19 a pandemic. Like you, I am concerned for my family, friends,…
Biopharma Brand Planning Strategy: Vision, Imperatives, and Tactics
Many years ago, when we first started working with emerging life sciences companies to provide a roadmap for the commercialization of their…